SCHEMBL8557987

SCHEMBL8557987

Nc1ccc(C(=O)N2Cc3ccccc3Sc3ccccc32)cc1

nearest known ligand 0.60

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 2/20 0.53
AVPR1A P37288 2/20 0.53
BCHE P06276 9/20 0.47
ACHE P22303 3/20 0.47
HSD17B3 P37058 2/20 0.44
P2RX4 Q99571 1/20 0.43
HPGD P15428 2/20 0.41
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559586 0.84 AVPR2 (0.46) AVPR2AVPR1AHSD17B3P2RX4HPGD
SCHEMBL8559583 0.82 BCHE (0.67) AVPR2AVPR1ABCHEACHEP2RX4
SCHEMBL8557423 0.80 ACHE (0.51) AVPR2AVPR1AACHEHSD17B3RAB9A
SCHEMBL8558207 0.79 AVPR2 (0.60) AVPR2AVPR1AHSD17B3P2RX4HPGD
SCHEMBL7341183 0.79 AVPR2 (0.57) AVPR2AVPR1AHSD17B3P2RX4HPGD
SCHEMBL31332440 0.78 HSD17B3 (0.68) BCHEHSD17B3
SCHEMBL8555635 0.78 HSD11B1 (0.47) BCHEACHEALDH1A1NPC1RAB9A
SCHEMBL8559312 0.76 AVPR1A (0.55) AVPR2AVPR1A
SCHEMBL8558825 0.76 AVPR1A (0.53) AVPR2AVPR1AKMT2A
SCHEMBL8556946 0.76 AVPR2 (0.55) AVPR2AVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0640592-B1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID CO (US) 1998-12-30 EP disclosed
WO-1997047624-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1997-12-18 WO disclosed
EP-0640592-A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists AMERICAN CYANAMID COMPANY (US) 1995-03-01 EP disclosed